Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec 12;87(4):549-61.
eCollection 2014 Dec.

The controversy surrounding bone morphogenetic proteins in the spine: a review of current research

Joshua W Hustedt  1 , Daniel J Blizzard  1
Affiliations
Review

The controversy surrounding bone morphogenetic proteins in the spine: a review of current research

Joshua W Hustedt et al. Yale J Biol Med. .

Abstract

Bone morphogenetic proteins have been in use in spinal surgery since 2002. These proteins are members of the TGF-beta superfamily and guide mesenchymal stem cells to differentiate into osteoblasts to form bone in targeted tissues. Since the first commercial BMP became available in 2002, a host of research has supported BMPs and they have been rapidly incorporated in spinal surgeries in the United States. However, recent controversy has arisen surrounding the ethical conduct of the research supporting the use of BMPs. Yale University Open Data Access (YODA) recently teamed up with Medtronic to offer a meta-analysis of the effectiveness of BMPs in spinal surgery. This review focuses on the history of BMPs and examines the YODA research to guide spine surgeons in their use of BMP in spinal surgery.

Keywords: bone morphogenetic proteins; postoperative complications; spinal fusion; spine.

PubMed Disclaimer

References

    1. Resnick DK. Evidence-based spine surgery. Spine (Phila Pa 1976) 2007;32(11):S15–S19. - PubMed
    1. Hsu WK, Wang JC. The use of bone morphogenetic protein in spine fusion. Spine J. 2008;8(3):419–425. - PubMed
    1. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech. 2002;15(5):337–349. - PubMed
    1. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11(6):471–491. - PubMed
    1. Haid RW Jr., Branch CL Jr., Alexander JT, Burkus JK. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J. 2004;4(5):527-38; discussion 38-9. - PubMed

Substances

LinkOut - more resources